Home Articles posted by PR News Desk (Page 624)
NEWS DESK

SHI GROUP LEADS THE WAY IN SUSTAINABLE DINING PRACTICES

SHI Group, under the visionary leadership of Diana Rysbaeva, proudly announces its steadfast commitment to environmental sustainability across its esteemed restaurants, including SHI, MOLI by SHI, and Jixiang Dim Sum. Through an array of innovative initiatives, SHI Group is setting the standard for eco-conscious dining experiences. At the heart of SHI Group’s
NEWS DESK

TradeSun Announces an Agreement With Wells Fargo

TradeSun and Wells Fargo have entered into an agreement that will enable Wells Fargo to leverage the industry leading trade finance and compliance digitization solution from TradeSun, using Artificial Intelligence (AI) and other advanced technologies to streamline the complex and manual processes employed globally within the banking industry. TradeSun’s major new release
NEWS DESK

Azizi Developments, MZ Architects partner for Azizi Venice

Azizi Developments, a leading private developer in the UAE, has announced its partnership with homegrown firm MZ Architects for the concept design of 11 buildings in its approximately AED 30 billion mixed-use development, Azizi Venice, located in Dubai South. Founded in 2002 by visionary architect Marwan Zgheib, MZ Architects stands as a beacon of innovation […]
NEWS DESK

dentsu MENA inaugurates regional HQ in Riyadh

dentsu MENA today announced that it has received its regional headquarters license from the Ministry of Investment and Ministry of Commerce in the Kingdom, reinforcing its commitment toward Vision 2030, driving the transformation program, and supporting ambitious local talent. As one of the region’s largest media and advertising networks, dentsu already supports many of
NEWS DESK

MRM Health Reports Safety and Positive Efficacy Data in Pouchitis in Phase 2a Clinical Study

MRM Health NV, a clinical-stage biopharmaceutical company developing innovative therapeutics for inflammatory, CNS and metabolic diseases, today reports positive topline results from its Phase 2a clinical trial with MH002 in the orphan disease indication Pouchitis. MRM Health’s MH002-PC-201 study was a multi-center, open-label clinical trial in 14 acute Pouchitis (PC)